Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Fluidigm funds DVS Sciences acquisition with $194mm debt offering

Executive Summary

Fluidigm Corp. (microfluidics instruments and consumables used in biological research, including single-cell genomics and applied genotyping) netted $194mm by publicly selling 2.75% 20-year convertible notes (including the full exercise of the overallotment).
Deal Industry
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Nanotechnology, Chips, etc.
Deal Status
  • Final
Deal Type
  • Financing
    • Convertible Debt
    • FOPO

Related Companies

UsernamePublicRestriction

Register